Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.
about
Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challengesPre-exposure prophylaxis for sexually-acquired HIV risk management: a reviewA systematic review of evidence to inform HIV prevention interventions among men who have sex with men in EuropeThe role of drug transporters in the kidney: lessons from tenofovirOral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challengesProfile of cabotegravir and its potential in the treatment and prevention of HIV-1 infection: evidence to datePre-exposure Prophylaxis for HIV Prevention: Why, What, Who and HowAntiretrovirals for primary HIV prevention: the current status of pre- and post-exposure prophylaxisPre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trialsWeek 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patientsKidney Disease and HIV Infection.Drug safety evaluation of oral tenofovir disoproxil fumarate-emtricitabine for pre-exposure prophylaxis for human immunodeficiency virus infection.Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation.ARV-based HIV prevention for women - where we are in 2014.Tenofovir: What We Have Learnt After 7.5 Million Person-Years of Use.Effectiveness and safety of oral HIV preexposure prophylaxis for all populationsChanges in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trialClinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in DeliveryTenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana.ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.Safety of oral tenofovir disoproxil fumarate-based pre-exposure prophylaxis for HIV prevention.Is Emtricitabine-Tenofovir Disoproxil Fumarate Pre-exposure Prophylaxis for the Prevention of Human Immunodeficiency Virus Infection Safer Than Aspirin?Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.Reversibility of Glomerular Renal Function Decline in HIV-Uninfected Men and Women Discontinuing Emtricitabine-Tenofovir Disoproxil Fumarate Pre-Exposure Prophylaxis.Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA PanelCost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa.Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trialAn overview of antiretroviral pre-exposure prophylaxis of HIV infection.Role of oral pre-exposure prophylaxis (PrEP) in current and future HIV prevention strategies.Recovery of Bone Mineral Density Following Discontinuation of Tenofovir-Based HIV Pre-Exposure Prophylaxis.Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings.Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.Low Risk of Proximal Tubular Dysfunction Associated With Emtricitabine-Tenofovir Disoproxil Fumarate Preexposure Prophylaxis in Men and Women.Pre-Exposure Prophylaxis: A Narrative Review of Provider Behavior and Interventions to Increase PrEP Implementation in Primary Care.Hair Levels of PrEP Drugs Measure Adherence and are Associated with Renal Decline Among Men/Transwomen in an Open Label PrEP Study.Kidney Disease in HIV: Moving beyond HIV-Associated Nephropathy.Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.
P2860
Q26825641-68BD8EF4-F612-49B2-A627-49DA741EFCBFQ26849762-28DE75C8-F34D-410A-A159-FC806F127968Q26866244-AF31FF12-0118-4470-9E16-70B1D1F995F3Q26866489-AD66BB40-34A6-4E30-A526-B087DFA5B7E6Q27023352-815615E6-36B5-479F-A2CC-C8BDF9C41CCDQ28079025-3DC5C6D1-AD99-43C4-958C-EB402224A0D0Q28080301-C4CA3575-CC4F-4FEB-AC4D-8EED6721D871Q28085433-4DE8CCB6-41E1-4A19-B0A7-3B296796C594Q28539443-E74227A7-462C-4BFA-84B2-EBD2C86FC36FQ28545183-6CFCD1C1-80CF-4CA0-BF5B-72A8DBAE0B73Q30234837-77F6AF66-D0F0-4D29-ADC5-11A476DFBCDCQ30249113-A900F54B-58F1-415E-917F-7528A067C022Q33656112-A1B39179-7A40-4C3A-BA0A-EE89752AE2F2Q34180729-3A71D6C6-5D62-46C1-96FC-9949EDA7D025Q34478840-883E932A-0CC3-41CB-A0CA-3AD3A62A8151Q34677217-1D5F88CE-35AE-4C1C-85EE-BA0FCA22DEC6Q35163040-ADE8C47F-CA58-4B02-9613-BD8D108088E4Q35541521-98F7CCF3-0A0D-4CC4-9E3E-E74600415EE3Q35858002-D6946D75-39A2-4E9D-9FAF-9BB572E14012Q35960654-7EAC2410-076A-4B0E-BCB8-6B9329BF70A3Q36576503-14CB2343-0C73-4BA1-8E1E-0AA7AD1998D3Q36586078-ACBAC660-DD21-4ACE-85C9-58B8DEE36373Q36591180-C645A739-1629-482C-9B70-64DAC3FDBBFCQ36619611-477C6E0B-BBA9-4AF6-B989-83C2D3622F26Q36629910-253DD0B3-22DD-4ABE-B32A-06B44E0AEE12Q36783183-1301136B-8C31-41E7-A38C-C08ED8C8A7E2Q37234729-E2E483C2-17FC-48C4-8408-26D01FE80215Q37298218-F95EFE03-AB46-4BBE-A541-36175343F130Q37377643-AD59C7EC-488E-4994-9F70-21FADEADF285Q37418247-10A15A29-AD5A-4C5D-A70B-44267EB1DE33Q38196410-51B0D812-5026-4D4A-8BCB-97B999AEA724Q38256787-EDBEE6F8-08CA-4AA2-9473-27E0DCDAF16EQ38714170-BF1E151E-99BE-421C-93F1-48958D5A4667Q38742749-47C63797-BBF6-45F5-9E46-63F5A7213006Q38821304-1D00EC6D-4186-454B-90D1-1C39DA9C9B3BQ38855217-CC4C64BE-98D9-44A6-A819-1A36A3064CC5Q38985811-A1243CDA-7DD9-4936-9EE2-42A774DDCBACQ40074158-3D53DE48-87D9-4168-B828-EAFFDCB9A0C8Q40103229-0ED6221C-AA05-45B4-984D-A530FFB282FFQ40396204-3109BD4C-CA68-4A78-80E8-090BB8DA1820
P2860
Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Changes in renal function asso ...... HIV pre-exposure prophylaxis.
@en
Changes in renal function asso ...... HIV pre-exposure prophylaxis.
@nl
type
label
Changes in renal function asso ...... HIV pre-exposure prophylaxis.
@en
Changes in renal function asso ...... HIV pre-exposure prophylaxis.
@nl
prefLabel
Changes in renal function asso ...... HIV pre-exposure prophylaxis.
@en
Changes in renal function asso ...... HIV pre-exposure prophylaxis.
@nl
P2093
P2860
P50
P1433
P1476
Changes in renal function asso ...... HIV pre-exposure prophylaxis.
@en
P2093
Albert Y Liu
David N Burns
David V Glidden
Esper Georges Kallás
Javier R Lama
Kathleen Mulligan
Marc M Solomon
Mauro Schechter
Suwat Chariyalertsak
Valdilea G Veloso
P2860
P304
P356
10.1097/QAD.0000000000000156
P407
P577
2014-03-01T00:00:00Z